Group 1 - The company, Weigao Group, has signed a non-binding letter of intent to acquire 100% of Weigao Puri's shares through Weigao Blood Purification, which will issue consideration shares to Weigao Puri's shareholders [1] - Weigao Blood Purification is primarily engaged in the research, production, and sales of blood purification medical products, including hemodialyzers and peritoneal dialysis solutions [1] - Weigao Puri focuses on the development and production of pre-filled drug delivery systems and automatic safety drug delivery systems, providing comprehensive drug delivery solutions for global biopharmaceutical companies [1] Group 2 - The board believes that if the potential transaction is completed, there will be synergies between Weigao Puri and Weigao Blood Purification, further expanding the overall business landscape of the group [2]
威高股份(01066)：威高血净拟发行对价股份收购威高普瑞100%的股权